ILT6/CD85e/LILRA3 Antibodies
We offer ILT6/CD85e/LILRA3 Antibodies for use in common research applications: ELISA, Intracellular Staining by Flow Cytometry, Western Blot. Each ILT6/CD85e/LILRA3 Antibody is fully covered by our Guarantee+, to give you complete peace of mind and the support when you need it. Our ILT6/CD85e/LILRA3 Antibodies can be used in a variety of model species: Human. Use the list below to choose the ILT6/CD85e/LILRA3 Antibody which is most appropriate for your research; you can click on each one to view full technical details, images, references, reviews and related products. Choose from our ILT6/CD85e/LILRA3 polyclonal antibodies and browse our ILT6/CD85e/LILRA3 monoclonal antibody catalog.
Alternate Names for ILT6/CD85e/LILRA3 Antibodies
anti-ILT6/CD85e/LILRA3 antibody, anti-LILRA3 antibody, anti-CD85 antigen-like family member E antibody, anti-CD85e antigen antibody, anti-HM31 antibody, anti-ILT-6 antibody, anti-ILT6CD85e antibody, anti-Immunoglobulin-like transcript 6 antibody, anti-leucocyte immunoglobulin-like receptor antibody, anti-Leukocyte immunoglobulin-like receptor 4 antibody, anti-leukocyte immunoglobulin-like receptor A3 antibody, anti-leukocyte immunoglobulin-like receptor subfamily A member 3 antibody, anti-leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member3 antibody, anti-LIR-4HM43e3 antibody, anti-LIR4CD85E antibody, anti-Monocyte inhibitory receptor HM43/HM31 antibody
11 Results for "ilt6-cd85e-lilra3" in Primary Antibodies
![Western Blot: ILT6/CD85e/LILRA3 Antibody (2E9) [H00011026-M01] - Analysis of LILRA3 expression in transfected 293T cell line by LILRA3 monoclonal antibody (M01), clone 2E9.Lane 1: LILRA3 transfected lysate(50.485 KDa).Lane 2: Non-transfected lysate.](http://images.novusbio.com/fullsize/ILT6-CD85e-LILRA3-Antibody-2E9-Western-Blot-H00011026-M01-img0002.jpg "Western Blot: ILT6/CD85e/LILRA3 Antibody (2E9) [H00011026-M01] - Analysis of LILRA3 expression in transfected 293T cell line by LILRA3 monoclonal antibody (M01), clone 2E9.Lane 1: LILRA3 transfected lysate(50.485 KDa).Lane 2: Non-transfected lysate.")
![Western Blot: ILT6/CD85e/LILRA3 Antibody [NBP1-98549] - Human OVCAR-3 Lane A: Primary Antibody Lane B: Primary Antibody + Blocking Peptide. Primary Antibody Concentration: 1.0 ug/mL. Peptide Concentration: 2.0 ug/mL lysate. Quantity: 25 ug/lane.](http://images.novusbio.com/fullsize/ILT6-CD85e-LILRA3-Antibody-Western-Blot-NBP1-98549-img0004.jpg "Western Blot: ILT6/CD85e/LILRA3 Antibody [NBP1-98549] - Human OVCAR-3 Lane A: Primary Antibody Lane B: Primary Antibody + Blocking Peptide. Primary Antibody Concentration: 1.0 ug/mL. Peptide Concentration: 2.0 ug/mL lysate. Quantity: 25 ug/lane.")
![Western Blot: ILT6/CD85e/LILRA3 Antibody [NBP1-98549] - Antibody Dilution: 1.0ug/ml Sample Tissue: Human Kidney.](http://images.novusbio.com/fullsize/ILT6-CD85e-LILRA3-Antibody-Western-Blot-NBP1-98549-img0003.jpg)
![Western Blot: ILT6/CD85e/LILRA3 Antibody [NBP2-19351] - Non-transfected (-) and transfected (+) 293T whole cell extracts (30 ug) were separated by 10% SDS-PAGE, and the membrane was blotted with LILRA3 antibody diluted at 1:2000. The HRP-conjugated anti-rabbit IgG antibody (NBP2-19301) was used to detect the primary antibody.](http://images.novusbio.com/fullsize/ILT6-CD85e-LILRA3-Antibody-Western-Blot-NBP2-19351-img0005.jpg "Western Blot: ILT6/CD85e/LILRA3 Antibody [NBP2-19351] - Non-transfected (-) and transfected (+) 293T whole cell extracts (30 ug) were separated by 10% SDS-PAGE, and the membrane was blotted with LILRA3 antibody diluted at 1:2000. The HRP-conjugated anti-rabbit IgG antibody (NBP2-19301) was used to detect the primary antibody.")
![Immunohistochemistry-Paraffin: ILT6/CD85e/LILRA3 Antibody [NBP2-19351] - Paraffin-embedded colon carcinoma. LILRA3 antibody [N2C2], Internal dilution: 1:250.](http://images.novusbio.com/fullsize/ILT6-CD85e-LILRA3-Antibody-Immunohistochemistry-Paraffin-NBP2-19351-img0003.jpg)
![Flow Cytometry: ILT6/CD85e/LILRA3 Antibody (060) [NBP2-90228] - Flow cytometric analysis of Human LILRA3(CD85e) expression on human whole blood monocytes. The cells were treated according to manufacturer's manual (BD Pharmingen™ Cat. No. 554714), stained with purified anti-Human LILRA3(CD85e), then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable monocytes.](http://images.novusbio.com/fullsize/ILT6-CD85e-LILRA3-Antibody-060-Flow-Cytometry-NBP2-90228-img0001.jpg "Flow Cytometry: ILT6/CD85e/LILRA3 Antibody (060) [NBP2-90228] - Flow cytometric analysis of Human LILRA3(CD85e) expression on human whole blood monocytes. The cells were treated according to manufacturer's manual (BD Pharmingen™ Cat. No. 554714), stained with purified anti-Human LILRA3(CD85e), then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable monocytes.")